Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H13NO2S |
Molecular Weight | 163.238 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[S+](C)CC[C@H](N)C([O-])=O
InChI
InChIKey=YDBYJHTYSHBBAU-YFKPBYRVSA-N
InChI=1S/C6H13NO2S/c1-10(2)4-3-5(7)6(8)9/h5H,3-4,7H2,1-2H3/t5-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28274096Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/methylmethionine-sulfonium-chloride.html | https://www.ncbi.nlm.nih.gov/pubmed/1362613 | https://www.ncbi.nlm.nih.gov/pubmed/20110751 | https://www.ncbi.nlm.nih.gov/pubmed/26225962
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28274096
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/methylmethionine-sulfonium-chloride.html | https://www.ncbi.nlm.nih.gov/pubmed/1362613 | https://www.ncbi.nlm.nih.gov/pubmed/20110751 | https://www.ncbi.nlm.nih.gov/pubmed/26225962
METHYLMETHIONINE (S-Methionine methyl sulfonium, SMMS) chloride is a derivative of methionine metabolism in some plants. Methylmethionine has therapeutic effects on gastrointestinal ulceration potentially via its ability to promote dermal fibroblast migration and growth. The natural derivative Methylmethionine is biosynthesized from L-methionine which is first converted to S-adenosylmethionine. The subsequent conversion, involving replacement of the adenosyl group by a methyl group is catalyzed by the enzyme methionine S-methyltransferase. Methylmethionine is particularly abundant in plants, being more abundant than methionine. S-Methylmethionine is sometimes referred to as vitamin U, but it is not considered a true vitamin. The term was coined in 1950 by Garnett Cheney for uncharacterized anti-ulcerogenic factors in raw cabbage juice that may help speed healing of peptic ulcers.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0070371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20110751 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1362613
500 mg 4 times daily for 2 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28274096
Evaluation of in vitro permeation and deposition of SMM (methylmethionine) through hairless mouse skin was carried out by using Keshary- Chien diffusion cells at 32°C, which have 1.77 cm2 of the surface area for diffusion. After sacrificing the hairless mice by cervical dislocation, the dorsal skin was cut to about 3 cm x 3 cm size and the subcutaneous fat was removed. Then, they were fixed between the donor and receptor cells, laying the stratum corneum toward the donor cells. The donor cells contained 2% (w/v) or 5% (w/v) SMM in the 50:50 (v/v) mixture (1.0 mL) of PG and double distilled water (DDW) with or without permeation enhancers, and were covered with parafilm to prevent evaporation. The receptor cells were filled with DDW (13.0 mL) and continuously stirred by magnetic bar. After applying SMM solution on the donor cells, 0.5 mL of the receptor solution was collected at 3, 6, 9, and 12 hr and added immediately with an equal volume of fresh media. SMM in the receptor solutions was analyzed using LC-MS/MS.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A02BX04
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
||
|
DSLD |
2308 (Number of products:2)
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4727-40-6
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
3485Y39925
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
m7440
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
10197842
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
SUB15707MIG
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
58252
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
CHEMBL45024
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
17728
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
100000076718
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
S-METHYLMETHIONINE
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY | |||
|
D014814
Created by
admin on Sat Dec 16 01:52:17 GMT 2023 , Edited by admin on Sat Dec 16 01:52:17 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)